Meet TD2 Oncology at ESMO 2025
Global Clinical Expertise for Complex Oncology Trials
We will be attending ESMO 2025 to connect with sponsors looking to accelerate their cancer drug development programs. Visit us at Booth #2038 to learn how our full-service global CRO supports your clinical strategy from first-in-human through registration, especially for complex, emerging modalities.
Global Trial Execution, Without the Complexity
Our European and U.S. teams provide the operational reach, regulatory strategy, and oncology expertise needed to execute globally while staying nimble. With experience across North America, Europe, and APAC, we help you meet patients where they are, and meet your milestones on time.
Specialized in Complex Modalities
We support novel oncology programs with unique demands:
- Radiopharmaceutical Trials: Full IND-to-FPI planning, radiation logistics, and global site readiness
- ADC Development:Integrated preclinical and clinical strategy to support safety and efficacy
- Hematology Studies:Proven expertise in liquid tumors and rare hematologic indications
Your Oncology Ecosystem Partner
From protocol design through site management, we don’t just execute, we collaborate. Our team brings scientific, regulatory, and operational insights that help you navigate complexity and reduce trial delays.
Can’t Make It to Booth #2038?
No problem, schedule a virtual follow-up meeting or catch our upcoming webinar, FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing.
Schedule a meeting today
Contact our experts to help advance your drug development program with our trusted regulatory or clinical research team.
